Suppr超能文献

胰高血糖素刺激后的及餐后血浆C肽值作为胰岛素分泌能力的指标。

Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity.

作者信息

Koskinen P J, Viikari J S, Irjala K M

机构信息

Central Laboratory, University Central Hospital of Turku, Finland.

出版信息

Diabetes Care. 1988 Apr;11(4):318-22. doi: 10.2337/diacare.11.4.318.

Abstract

Basal, postprandial (2 h after breakfast), and glucagon-stimulated plasma C-peptide concentrations were determined in a group of 36 adult diabetic patients. Basal and postprandial C-peptide values were measured on consecutive days to estimate the degree of variation of C-peptide secretion. In a subgroup of 15 diabetic patients treated chronically with diet and oral hypoglycemic agents (sulfonylureas or a combination of sulfonylureas and metformin), we studied whether administration of sulfonylureas immediately before breakfast had any effect on postprandial C-peptide values. Absolute differences between two consecutive fasting C-peptide concentrations in insulin-requiring patients were less than 0.1 nM in all but 1 patient, in whom the difference was 0.18 nM. In subjects treated with oral hypoglycemic agents the median difference was 0.12 nM (range 0-0.38 nM). Absolute differences between two consecutive postprandial C-peptide concentrations were all less than 0.1 nM in insulin-requiring patients. No significant difference was found between postprandial C-peptide concentrations with or without preceding administration of oral hypoglycemic agents (medians 1.35 and 1.30 nM, respectively). Glucagon-stimulated C-peptide concentrations were somewhat higher than the postprandial values. However, equal discrimination between insulin-requiring and non-insulin-requiring diabetic patients was found by measuring postprandial or glucagon-stimulated C-peptide concentrations.

摘要

对36例成年糖尿病患者测定了基础状态、餐后(早餐后2小时)以及胰高血糖素刺激后的血浆C肽浓度。连续几天测量基础和餐后C肽值,以评估C肽分泌的变化程度。在15例长期接受饮食和口服降糖药(磺脲类或磺脲类与二甲双胍联合用药)治疗的糖尿病患者亚组中,我们研究了早餐前立即给予磺脲类药物是否对餐后C肽值有任何影响。除1例患者差异为0.18 nM外,所有需要胰岛素治疗的患者连续两次空腹C肽浓度的绝对差异均小于0.1 nM。在接受口服降糖药治疗的患者中,中位数差异为0.12 nM(范围0 - 0.38 nM)。需要胰岛素治疗的患者连续两次餐后C肽浓度的绝对差异均小于0.1 nM。餐前服用或未服用口服降糖药时的餐后C肽浓度之间未发现显著差异(中位数分别为1.35和1.30 nM)。胰高血糖素刺激后的C肽浓度略高于餐后值。然而,通过测量餐后或胰高血糖素刺激后的C肽浓度,在需要胰岛素治疗和不需要胰岛素治疗的糖尿病患者之间发现了相同的区分度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验